Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S (ASND) is a healthcare company (biotechnology) based in Denmark. The share price is $266.65, down 1.87% on the day, which values the company at $17.49B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.

Key facts

Share price
$266.65−1.87% today
Market value
$17.49B
P/E ratio
17.5×last 12 months
Forward P/E
22.0×
Funk Score
55/100
200-week average
$160.8566% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Ascendis Pharma A/S in more detail

ASND trades at 17.5× its last twelve months' earnings, 22.0× next year's expected earnings, 14.5× sales. It sits 66% above its 200-week average of $160.85.

Its Funk Score is 55 out of 100 (financial strength 3.8, profitability 2.6, growth 10.0, each out of 10).

In its favour: Operating margin is expanding. Worth checking: Share count keeps rising; Thin interest cover.

2 of the superinvestors tracked here hold ASND, including Peter Kolchinsky (23.8% of the portfolio), Polen Capital team (0.1% of the portfolio).

Superinvestors holding ASND

2 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:ASND vs NBIX (Ascendis Pharma A/S vs Neurocrine Biosciences)ASND vs CRL (Ascendis Pharma A/S vs Charles River Laboratories International)ASND vs EXEL (Ascendis Pharma A/S vs Exelixis)ASND vs ICLR (Ascendis Pharma A/S vs ICON)ASND vs RVTY (Ascendis Pharma A/S vs Revvity)

All health care companies by market valueLargest companies in DenmarkAll stocks A–Z

Ascendis Pharma A/S (ASND): questions and answers

What is ASND's P/E ratio?

Ascendis Pharma A/S trades at 17.5× its last twelve months' earnings and 22.0× next year's expected earnings.

What is Ascendis Pharma A/S's market cap?

Ascendis Pharma A/S is valued at $17.49B at a share price of $266.65.

Is ASND above its 200-week moving average?

Yes. ASND is 65.8% above its 200-week average of $160.85. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Ascendis Pharma A/S growing?

Over the last three fiscal years Ascendis Pharma A/S's revenue grew 141.4% a year.

Does ASND pay a dividend?

Ascendis Pharma A/S does not currently pay a regular dividend.

Which famous investors own ASND?

In their latest quarterly filings, Peter Kolchinsky (23.8% of the portfolio), Polen Capital team (0.1% of the portfolio) hold ASND. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Ascendis Pharma A/S (ASND) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ASND

Underlying data: Yahoo Finance; company filings with the SEC.